Validation of a French Version of the DHEQ

Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · Jun 17, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on validating a French version of a questionnaire called the Dentine Hypersensitivity Experience Questionnaire (DHEQ-fr). This questionnaire is designed to understand how dentin hypersensitivity (a sharp, brief pain in teeth) affects patients' quality of life. The goal is to ensure that this tool can accurately help diagnose dentin hypersensitivity and evaluate patients' experiences, so they can receive better treatment. The study will take place at three centers in France and will involve adults who have varying levels of dentin hypersensitivity as well as a control group of individuals without this condition.

To participate in the trial, patients should be able to understand the study's purpose. However, individuals with certain dental issues, recent dental treatments, or specific medical conditions, such as being pregnant or participating in other clinical studies, will not be eligible. Participants can expect to complete the DHEQ-fr and undergo a follow-up test about two weeks later to ensure the questionnaire works well. This study aims to gather important data that could lead to improved diagnosis and treatment options for those suffering from dentin hypersensitivity.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients who are able to understand the study
• Exclusion Criteria:
• • Teeth with other pathologies in addition to HD (carious lesions, cracked enamel, etc.);
• • Abutment teeth for fixed or removable dentures and crown teeth;
• • Teeth with restorations involving the inner third of the dentin and/or restorations involving the dentinary/root exposure area;
• • Patients who have been on or have undergone desensitizing therapy for HD in the past three months;
• • Patients who have received periodontal surgery within the last three months;
• • Patients with orthodontic devices who have interrupted orthodontic treatment in the last three months;
• • Pregnant or breastfeeding patients;
• • Patients under guardianship, curatorship, safeguard of justice
• • Patients deprived of liberty
• • Patients participating in any other clinical study.